ELISA for VEGF
US7541160B2 · kind B2 · utility
1Cited by
14References
9Claims
0Family size
Inventors
Key dates
| Filing date | Nov 1, 2004 |
| Grant date | Jun 2, 2009 |
| Priority date | — |
| Expiry date | Jun 6, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/813
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The vascular endothelial growth factor (VEGF) activity in a patient's bloodstream or other biological sample can serve as a diagnostic and prognostic index for cancer, diabetes, heart conditions, and other pathologies. Antibody-sandwich ELISA method and kits for VEGF as an antigen were developed to detect VEGF levels in biological samples from animal models and human patients and are used as a diagnostic/prognostic index.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.